The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm
Open accessAbstract
In the setting of catheter-related bloodstream infections, intraluminal antibiotic lock therapy could be useful for the salvage of vascular catheters. In this in vitro study, we investigated the efficacies of the newer antibiotics daptomycin, linezolid, and tigecycline, in comparison with those of vancomycin, minocycline, and rifampin, against methicillin-resistant Staphylococcus aureus (MRSA) embedded in biofilm. We also assessed the emergence of MRSA strains resistant to these antibiotics, alone or in combination with rifampin, after 4-hour daily use for catheter lock therapy. Minocycline, daptomycin, and tigecycline were more efficacious in inhibiting MRSA in biofilm than linezolid, vancomycin, and the negative control ( P < 0.001) after the first day of exposure to these antibiotics, with minocycline being the most active, followed by daptomycin and then tigecycline, and with vancomycin and linezolid lacking activity, similar to the negative control. After 3 days of 4-hour daily exposures, daptomycin was the fastest in eradicating MRSA from biofilm, followed by minocycline and tigecycline, which were faster than linezolid, rifampin, and vancomycin ( P < 0.001). When rifampin was used alone, it was the least effective in eradicating MRSA from biofilm after 5 days of 4-hour daily exposures, as it was associated with the emergence of rifampin-resistant MRSA. However, when rifampin was used in combination with other antibiotics, the combination was significantly effective in eliminating MRSA colonization in biofilm more rapidly than each of the antibiotics alone. In summary, daptomycin, minocycline, and tigecycline should be considered further for antibiotic lock therapy, and rifampin should be considered for enhanced antistaphylococcal activity but not as a single agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Self-citationInfection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
Darouiche, R. O., Raad, I. I., Heard, S. O., Thornby, J. I., Wenker, O. C., Gabrielli, A., Berg, J., Khardori, N., Hanna, H., Hachem, R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400101 · Cited by 804
Self-citationKuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
Raad, I., Darouiche, R., Dupuis, J., Abi-Said, D., Gabrielli, A., Hachem, R., Wall, M., Harris, R., Jones, J., Buzaid, A., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-4-199708150-00002 · Cited by 610
Self-citationRaad, I., Costerton, W., Sabharwal, U., Sadlowski, M., Anaissie, E., & Bodey, G. P. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.400 · Cited by 553
Self-citationSaginur, R., StDenis, M., Ferris, W., Aaron, S. D., Chan, F., Lee, C., & Ramotar, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.55-61.2006 · Cited by 332
Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution
Krishnasami, Z., Carlton, D., Bimbo, L., Taylor, M. E., Balkovetz, D. F., Barker, J., & Allon, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00201.x · Cited by 278
Heparin Stimulates Staphylococcus aureus Biofilm Formation
Shanks, R. M. Q., Donegan, N. P., Graber, M. L., Buckingham, S. E., Zegans, M. E., Cheung, A. L., & O'Toole, G. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4596-4606.2005 · Cited by 266
Antibiotics and prevention of microbial colonization of catheters
Raad, I., Darouiche, R., Hachem, R., Sacilowski, M., & Bodey, G. P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2397 · Cited by 211
Self-citationEvans, R. C., & Holmes, C. J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.6.889 · Cited by 199
Hanna, H., Benjamin, R., Chatzinikolaou, I., Alakech, B., Richardson, D., Mansfield, P., Dvorak, T., Munsell, M. F., Darouiche, R., Kantarjian, H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.124 · Cited by 191
Self-citationTambe, S. M., Sampath, L., & Modak, S. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.589 · Cited by 177
Petersen, P. J., Bradford, P. A., Weiss, W. J., Murphy, T. M., Sum, P. E., & Projan, S. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2595-2601.2002 · Cited by 169
Raad, I., Chatzinikolaou, I., Chaiban, G., Hanna, H., Hachem, R., Dvorak, T., Cook, G., & Costerton, W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3580-3585.2003 · Cited by 166
Self-citationCurtin, J., Cormican, M., Fleming, G. T. A., Kelehan, J., & Colleran, E. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3145-3148.2003 · Cited by 115
Bleyer, A. J., Mason, L., Russell, G. B., RAAD, I. I., & Sherertz, R. J. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502578 · Cited by 104
Self-citationChatzinikolaou, I., Zipf, T. F., Hanna, H. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/344952 · Cited by 89
Self-citationLonguet, P., Douard, M. C., Arlet, G., Molina, J., Benoit, C., & Leport, C. (2001) · Clinical Infectious Diseases · doi:10.1086/320746 · Cited by 67
Labthavikul, P., Petersen, P. J., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3967-3969.2003 · Cited by 55
Lotter, K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl270 · Cited by 28
Cited by
Staphylococcus epidermidis — the 'accidental' pathogen
Otto, M. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2182 · Cited by 1,808
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies
Schilcher, K., & Horswill, A. R. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-19 · Cited by 706
Intravascular catheter-related infections: advances in diagnosis, prevention, and management
Raad, I., Hanna, H., & Maki, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70235-9 · Cited by 525
Self-citation
Metadata
- Authors
- Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R., & Hachem, R.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-05
- Volume
- 51
- Issue
- 5
- Pages
- 1656-1660
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2143661366
- Cited by
- 350
- References
- 23
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.